Tag: pain relief
Intermittent stimulation of the DRG produces comparable chronic pain results to...
Intermittent dorsal root ganglion stimulation (DRG-S) has been shown to produce comparable results to continuous stimulation across a two-week period, as reported in Neuromodulation:...
Saluda announces sustained, long-term pain relief results with closed-loop SCS in...
Saluda Medical today announced long-term results from its double-blind, Level 1 EVOKE trial, which have been published in JAMA Neurology and demonstrate superior, sustained pain...
SPR Therapeutics announces expanded FDA clearance for SPRINT peripheral nerve stimulation...
SPR Therapeutics has obtained clearance from the US Food and Drug Administration (FDA) of a broader indication for the usage of its SPRINT peripheral...
Boston Scientific launches FAST—a new therapy for spinal cord stimulation
Boston Scientific has announced the European launch of FAST—a new, fast-acting sub-perception therapy that the company says is clinically proven to demonstrate significant and...
Presidio Medical publishes clinical and preclinical research on ULF neuromodulation therapy
Presidio Medical has announced that research involving its novel ultra-low frequency (ULF) neuromodulation therapy has been published in Science Translational Medicine. The publication, titled...
Study shows “major energy savings” can be achieved in spinal cord...
The results of the HALO (High and low frequency options) study, which are published online in the scientific journal Neuromodulation: Technology at the Neural...
Burst stimulation of the spinal cord leads to greater pain modulation...
Data from a substudy of SUNBURST suggest that burst stimulation of the spinal cord regulates the medial pain pathway to a greater extent than...
Medtronic’s Evolve workflow with spinal cord stimulation demonstrates effective pain relief...
Medtronic has announced primary endpoint (three-month) results of the Vectors post-market clinical study that demonstrated effective pain relief and improved function in patients with...
Evoke: The first RCT to measure spinal cord activations in response...
The protocol design for a multicentre, prospective, randomised, double-blind study comparing ECAP- (evoked compound action potential) controlled closed-looped with open-loop, fixed output spinal cord...
Stimwave receives FDA clearance for first Wireless SCS System with iPhone-iWatch...
Stimwave Technologies has announced that it has received US Food and Drug Administration (FDA) clearance for the WaveCrest Mobile iOS platform patient controllers for...
FDA approves new SynchroMed II myPTM Personal Therapy Manager that enables...
Medtronic has announced US Food and Drug Administration (FDA) approval of the new SynchroMed II myPTM Personal Therapy Manager for patients with chronic pain....
Medtronic launches the Control Workflow to help eliminate oral opioids and...
Medtronic has announced the US launch of the Control Workflow, an evidence-based approach for use with the SynchroMed II intrathecal drug delivery system ("Medtronic...
